Serum coating enables feeder-free culture of naive human pluripotent stem cells preserving developmental potential
Naive human pluripotent stem cells (hPSCs) represent a pre-implantation epiblast state able to efficiently differentiate into embryonic and extraembryonic pre-implantation lineages and to self-organise in vitro into blastocyst-like structures called blastoids. Naive hPSC maintenance routinely relies on co-culture with mouse embryonic fibroblast (MEFs) as feeder cells, a method prone to variability and analytical confounders. Here, we describe a feeder-free culture system based on serum coating that supports long-term maintenance of naive hPSCs. Across five laboratories, 30 serum batches were evaluated for the expansion of eight naive hPSCs lines for up to 25 passages. Mass spectrometry analysis identified fibronectin and collagens as extracellular matrix proteins consistently present in serum coating. Cells cultured on serum coating displayed growth kinetics, clonogenic capacity, mutation rates, and global gene expression profiles comparable to MEF-based cultures. Importantly, serum-cultured naive hPSCs efficiently underwent germ layer specification, retained trophectoderm competence, and generated blastoids with efficiency similar to MEF-based cultures. Collectively, serum coating provides a scalable, cost-effective, and robust alternative to feeder-based systems, preserving genomic stability and developmental potential while eliminating MEF-associated disadvantages and variability. This platform facilitates large-scale applications of naive hPSCs and enables more reproducible mechanistic studies.
Authors
- Emiel van Genderen
- Sherif Khodeer (ORCID: https://orcid.org/0000-0001-6851-8568)
- Jan J Żylicz (ORCID: https://orcid.org/0000-0001-9622-5658)
- Davide Cacchiarelli (ORCID: https://orcid.org/0000-0002-9621-6716)
- Andrea Drusin
- Michael Oberhuemer (ORCID: https://orcid.org/0000-0003-2273-2782)
- Sam Samuel Franciscus Allegonda van Knippenberg (ORCID: https://orcid.org/0000-0001-5656-3046)
- Thi Xuan Ai Pham (ORCID: https://orcid.org/0000-0003-3866-2002)
- Vincent Pasque (ORCID: https://orcid.org/0000-0002-5129-0146)
- Giada Rossignoli (ORCID: https://orcid.org/0000-0001-6263-3549)
- Anna Osnato (ORCID: https://orcid.org/0000-0001-5241-1512)
- Martin Leeb (ORCID: https://orcid.org/0000-0001-5114-4782)
- Paolo Grumati (ORCID: https://orcid.org/0000-0002-9942-9389)
- Mairim Alexandra Solís (ORCID: https://orcid.org/0000-0001-9911-2149)
- G Panebianco
- Nicolo Magri
- Ida Sophie Brun
- Irene Zorzan
- Moritz Becker
- Anne Wenzel
- Graziano Martello
- Nicolas Rivron
- Paolo Martini
- Chiara Colantuono
Institutions
- Instituto Conmemorativo Gorgas de Estudios de la Salud (PA)
- Institute of Molecular Biotechnology (AT)
- Babraham Institute (GB)
- Austrian Academy of Sciences (AT)
- University of Padua (IT)
- Novo Nordisk Foundation (DK)
- Max Perutz Labs (AT)
- Institute of Applied Science and Intelligent Systems (IT)
- Vienna Biocenter (AT)
- Scuola Superiore Meridionale (IT)
- Telethon Institute Of Genetics And Medicine (IT)
- University of Naples Federico II (IT)
- Medical University of Vienna (AT)
- University of Brescia (IT)
- KU Leuven (BE)
Publication Details
- Journal
- The EMBO Journal
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1038/s44318-026-00714-2
- Citations
- 1
- Primary Topic
- Pluripotent Stem Cells Research
- Type
- article
- Field-Weighted Citation Impact
- 22.24